Gipc1-KO Mouse
一般名
Gipc1-KO
製品ID
S-KO-12515
背景情報
C57BL/6JCya
系統ID
KOCMP-67903-Gipc1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Gipc1-KO Mouse(カタログ番号S-KO-12515)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Gipc1-KO
系統ID
KOCMP-67903-Gipc1-B6J-VA
遺伝子名
製品ID
S-KO-12515
遺伝子別名
GIPC, TIP-2, TaxIP2, Semcap1, Glut1CIP, Rgs19ip1
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000019577
NCBIトランスクリプトID
NM_018771
ターゲット領域
Exon 2~4
有効領域の大きさ
~2.1 kb
遺伝子研究の概要
Gipc1, also known as GAIP interacting protein, C terminus 1, is a multifunctional scaffold protein. It plays diverse roles in various biological processes, interacting with multiple proteins and being involved in different pathways. For instance, it binds to the C-terminus of β1 -adrenergic receptor, impacts lipid and cholesterol metabolism by interacting with SR -B1, and is associated with signaling pathways like PDGFR/PI3K/AKT [3,5,7].
In disease-related research, GIPC1 knockdown reduced MACC1-induced cell migration and invasion in colon cancer, and GIPC1 suppression decreased tumor growth and metastasis in mice transplanted with MACC1-overexpressing CRC cells, suggesting its role in cancer metastasis [1]. In gastric cancer, GIPC1 knockdown inhibited cell proliferation and migration by blocking the PDGFR/PI3K/AKT signaling pathway, while overexpression had the opposite effect, and in vivo, GIPC1 silencing decreased tumor growth and migration in nude mice [3]. In oculopharyngodistal myopathy (OPDM), an abnormal GGC repeat expansion in the 5' UTR of GIPC1 was identified in some patients, with altered mRNA levels [4]. In movement disorders, approximately 1% of patients might harbor GIPC1 CGG repeat expansion, which may lead to diseases related to intranuclear inclusions [2]. In breast cancer, high expression of GIPC1 in primary tumors was associated with a higher likelihood of bone metastasis and death in control patients, and zoledronate had a substantial effect in patients with high GIPC1 expression [6]. Also, overexpressing GIPC1 protected against pathological cardiac remodelling in mice as GIPC1 cKO mice showed spontaneous cardiac hypertrophy, fibrosis, and systolic dysfunction, while AAV9-mediated GIPC1 overexpression attenuated isoproterenol-induced pathological cardiac remodelling [5].
In conclusion, Gipc1 is involved in multiple biological functions and is closely associated with various diseases such as cancer, myopathies, movement disorders, and cardiac diseases. Gene knockout or knockdown models in mice have been crucial in revealing its functions in these disease conditions, providing valuable insights into disease mechanisms and potential therapeutic targets.
References:
1. Siegel, Franziska, Schmidt, Hannes, Juneja, Manisha, Schlag, Peter M, Stein, Ulrike. 2023. GIPC1 regulates MACC1-driven metastasis. In Frontiers in oncology, 13, 1280977. doi:10.3389/fonc.2023.1280977. https://pubmed.ncbi.nlm.nih.gov/38144523/
2. Fan, Yu, Shen, Si, Yang, Jing, Xu, Yuming, Shi, Changhe. 2022. GIPC1 CGG Repeat Expansion Is Associated with Movement Disorders. In Annals of neurology, 91, 704-715. doi:10.1002/ana.26325. https://pubmed.ncbi.nlm.nih.gov/35152460/
3. Li, Tingting, Zhong, Wei, Yang, Liu, Song, Gang, Luo, Fanghong. 2023. GIPC1 promotes tumor growth and migration in gastric cancer via activating PDGFR/PI3K/AKT signaling. In Oncology research, 32, 361-371. doi:10.32604/or.2023.043807. https://pubmed.ncbi.nlm.nih.gov/38186571/
4. Deng, Jianwen, Yu, Jiaxi, Li, Pidong, Hong, Daojun, Wang, Zhaoxia. 2020. Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal Myopathy. In American journal of human genetics, 106, 793-804. doi:10.1016/j.ajhg.2020.04.011. https://pubmed.ncbi.nlm.nih.gov/32413282/
5. Sun, Xi, Han, Yanna, Yu, Yahan, Zhao, Dan, Bai, Yunlong. 2024. Overexpressing of the GIPC1 protects against pathological cardiac remodelling. In European journal of pharmacology, 971, 176488. doi:10.1016/j.ejphar.2024.176488. https://pubmed.ncbi.nlm.nih.gov/38458410/
6. Westbrook, Jules A, Cairns, David A, Peng, Jianhe, Coleman, Robert E, Brown, Janet E. 2016. CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment. In Journal of the National Cancer Institute, 108, . doi:10.1093/jnci/djv360. https://pubmed.ncbi.nlm.nih.gov/26757732/
7. Zhang, Ziyu, Zhou, Qian, Liu, Rui, Guo, Zhigang, Hu, Zhigang. 2021. The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake. In The Journal of biological chemistry, 296, 100616. doi:10.1016/j.jbc.2021.100616. https://pubmed.ncbi.nlm.nih.gov/33811857/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
